Details for New Drug Application (NDA): 017122
✉ Email this page to a colleague
NDA 017122 describes DARVOCET-N 50, which is a drug marketed by Xanodyne Pharm and is included in one NDA. Additional details are available on the DARVOCET-N 50 profile page.
The generic ingredient in DARVOCET-N 50 is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.
The generic ingredient in DARVOCET-N 50 is acetaminophen; propoxyphene napsylate. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; propoxyphene napsylate profile page.
Summary for 017122
| Tradename: | DARVOCET-N 50 |
| Applicant: | Xanodyne Pharm |
| Ingredient: | acetaminophen; propoxyphene napsylate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 325MG;50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 650MG;100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
